Hot Topic: COVID-19 and Breast Cancer
In this video, Deborah L. Toppmeyer, MD, director of the Stacy Goldstein Breast Cancer Center at Rutgers Cancer Institute of New Jersey, discusses:
- how breast cancer treatment strategies – particularly in early-onset breast cancer – needed to change “literally overnight” at the onset of the COVID-19 pandemic;
- the impact of the complete shutdown of breast cancer screening during COVID-19 pandemic;
- the importance of discussing COVID-19 vaccination and its boosters, as well as influenza vaccination, with breast cancer patients;
- how “we have gotten a bit complacent” compared with the beginning of the pandemic, and how COVID-19 “still has a significant burden on our hospitals, our health care providers,” and patients who have developed long COVID-19;
- why education and “listening to patients’ concerns” on COVID-19 vaccines are essential to address vaccine hesitancy; and
- areas where future research on COVID-19 and breast cancer should focus, like the long-term impact of delayed screening during the COVID-19 pandemic.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.